Exodx prostate (intelliscore)
Ended Awarded Last action
- Contract number
- 36C24721F0200
- Awardee
-
Exosome Diagnostics Inc. UEI TCKUCULVVY39
- Awarding agency
-
Veterans Integrated Service Network 7
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $332,236
Award facts
- Contract value 76% obligated
- $438,951.68 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Augusta, GA 30904, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$82,603 | |
| Exercise an Option | $150,304 | |
| Other Administrative Action | -$150,304 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $150,304 | |
| Funding Only Action | -$106,716 | |
| Exercise an Option | $150,304 | |
| Funding Only Action | -$79,661 | |
| Exercise an Option | $150,304 | |
| Other Administrative Action | $0 | |
| Original award | $150,304 |
Show all 11
About this award
Exosome Diagnostics Inc., a Bio-Techne Corporation subsidiary based in Waltham, Massachusetts, received a delivery order award from Veterans Integrated Service Network (VISN) 7 on April 1, 2021, for its ExoDx Prostate (IntelliScore) diagnostic testing services. The delivery order, valued at $438,951.68 on a firm fixed-price basis, is issued under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and does not utilize a set-aside designation. Performance will be completed at the contractor's facility in Augusta, Georgia, with an ultimate completion date of March 31, 2026. The award supports the Veterans Affairs' prostate cancer screening initiatives by providing non-invasive, urine-based liquid biopsy tests that analyze exosomal RNA biomarkers to assess risk of clinically significant prostate cancer among eligible veterans.
This delivery order represents a continuation of Exosome Diagnostics' established relationship with the VA system, which has awarded the company multiple contracts across several VISNs for the same diagnostic services. The company also maintains a significant Blanket Purchase Agreement with VISN 1 valued at $1.35 million for an estimated 1,800 tests over five years, demonstrating the VA's confidence in the company's specialized diagnostic capabilities. The contract enables delivery of innovative cancer detection solutions that support the department's mission to provide advanced healthcare options to the veteran population.
Quick answers
Who was awarded contract 36C24721F0200?
36C24721F0200 was awarded to Exosome Diagnostics Inc. by Veterans Integrated Service Network 7 (Veterans Health Administration) on April 1, 2021.
How much is contract 36C24721F0200 worth?
The government has obligated $332,236 on 36C24721F0200. Its current value, with exercised options, is $438,952.
Is contract 36C24721F0200 an order under another contract?
Yes. 36C24721F0200 is a delivery order under 36F79720D0097, a federal supply schedule, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract 36C24721F0200 competed?
The extent of competition for 36C24721F0200 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award